Baseline characteristics of participants
| Variable | No. (%) or mean ± SD | |
|---|---|---|
| Pharmacist-led group n = 143 | Nurse-led group n = 136 | |
| General | ||
| Age, yr | 68.8 ± 11.1 | 66.3 ± 11.3 |
| Men | 87 (60.8) | 75 (55.2) |
| Systolic blood pressure, mm Hg | 134.9 ± 17.53 | 133.8 ± 16.0 |
| Diastolic blood pressure, mm Hg | 76.0 ± 10.4 | 77.5 ± 10.4 |
| LDL cholesterol, mmol/L | 3.20 ± 0.84 | 3.27 ± 0.84 |
| HDL cholesterol, mmol/L | 1.30 ± 0.40 | 1.27 ± 0.38 |
| Total:HDL ratio | 4.23 ± 1.36 | 4.40 ± 1.24 |
| Glomerular filtration rate, mL/min | 79.1 ± 18.0 | 79.0 ± 21.5 |
| Serum creatinine, umol/L | 84.0 ± 21.2 | 82.6 ± 23.3 |
| Body mass index | 28.2 ± 4.1 | 29.5 ± 4.9 |
| Waist circumference, cm | 95.1 ± 11.2 | 96.9 ± 11.5 |
| Men | 98.8 ± 8.6 | 100.3 ± 8.7 |
| Women | 89.6 ± 12.4 | 92.6 ± 13.1 |
| Qualifying event | ||
| Stroke | 65 (45.4) | 55 (40.4) |
| Transient ischemic attack | 73 (51.1) | 76 (55.9) |
| Ocular stroke | 5 (3.5) | 5 (3.7) |
| ABCD score (out of 7) | ||
| Low (1–3) | 20 (27.4) | 31 (40.8) |
| Moderate (4–5) | 43 (53.1) | 38 (50.0) |
| High (6–7) | 10 (13.7) | 7 (9.2) |
| Modified Rankin score | ||
| No significant disability | 72 (85.7) | 70 (86.4) |
| Slight disability | 11 (13.1) | 11 (13.6) |
| Moderate disability | 1 (1.2) | 0 (0) |
| Comorbidities | ||
| Prior stroke | 47 (32.9) | 41 (30.2) |
| Hypertension | 102 (71.3) | 101 (74.3) |
| Coronary artery disease | 19 (13.3) | 12 (8.8) |
| Heart failure | 2 (1.4) | 3 (2.2) |
| Atrial fibrillation | 12 (8.4) | 12 (8.8) |
| Dyslipidemia | 114 (79.7) | 116 (85.3) |
| Peripheral arterial disease | 1 (0.7) | 2 (1.5) |
| Diabetes mellitus | 25 (17.5) | 16 (11.8) |
| Chronic kidney disease* | 17 (15.6) | 36 (29.0) |
| COPD | 6 (4.2) | 3 (2.2) |
| Left ventricular hypertrophy | 21 (14.7) | 9 (6.6) |
| Current smoker | 24 (16.8) | 16 (11.8) |
| Former smoker | 63 (44.1) | 55 (40.4) |
| Medications | ||
| Antihypertensive | 111 (77.6) | 107 (78.7) |
| Antiplatelet | 141 (98.6) | 133 (97.8) |
| Statin | 115 (80.4) | 121 (89.0) |
| Other lipid-lowering agent | 2 (1.4) | 2 (1.5) |
| Warfarin | 8 (5.9) | 6 (4.7) |
| Questionnaires | ||
| Self-reported adherence ≥ 75% for blood pressure or lipid-lowering agents | 135 (94.4) | 127 (93.3) |
| Overall self-rated health† | 3.18 ± 0.86 | 3.20 ± 0.83 |
| EQ-5D index score | 0.83 ± 0.14 | 0.86 ± 0.12 |
| Health care satisfaction† | 4.28 ± 0.75 | 4.39 ± 0.67 |
| Physical activity meets Canadian guidelines‡ | 9 (6.3) | 6 (4.4) |
Note: COPD = chronic obstructive pulmonary disease, EQ-5D = EuroQol Health Questionnaire, HDL = high-density lipoprotein, LDL = low-density lipoprotein, SD = standard deviation.
↵* Estimated glomerular filtration rate < 60 based on the MDRD (modification of diet in renal disease) equation.
↵† Scored on a 5-point Likert scale with 5 being excellent and 1 being poor.
↵‡ Individuals reporting at least 120 minutes of moderate or strenuous physical activity per week.